MGI Announces Milestone of 1,000 Sequencers Installed and Opens Early Access Program for Groundbreaking Ultra-High-Throughput Sequencer, MGISEQ-T7

News provided by

MGI

08 Jan, 2019, 03:39 IST

SAN JOSE, Calif., Jan. 7, 2019 /PRNewswire/ -- MGI, established in 2016, a company committed to building core tools and technology to lead life science, announced it has reached a new milestone of 1,000 MGI sequencers installed in 16 countries. MGI Chief Operating Officer Dr. Hui Jiang also announced the availability of MGI's early access program for its newest ultra-high-throughput genetic sequencer, MGISEQ-T7, during a presentation at China Focus@JPM Week on the eve of the 37th annual J.P. Morgan Healthcare Conference.

Continue Reading

The MGISEQ-T7 vastly improves speed, throughput and flexibility of DNA sequencing by enabling simultaneous but independent operation of up to four flow cells in a single run. The innovative quad-flowcell platform allows multiple flow cells with different read lengths and applications to be processed separately at any time. Sequencing of PE150 takes less than 24 hours at full load to complete. The MGI proprietary technologies, including DNBseq™ used in T7, deliver exceptionally high accuracy and improve efficiency through upgrades to the flowcell, fluidics, and biochemical and optical system. The platform can produce up to 6Tb of daily data, equivalent to up to 60 whole human genomes in a single day.